Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
opioid
3
×
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
indiana blog main
indiana top stories
multiple myeloma
multiple sclerosis
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adalimumab (humira)
aducanumab
aduro biotech
adverse events database
affordable care act
What
bio
drug
roundup
abbvie’s
alkermes
antipsychotic
approval
barbecuing
benefits
biogen’s
biopharmaceutical
camping
cardiologist
caveats
center
check
cholesterol
commonly
companies
conference
convo
day
designed
earlier
effect
failures
favor
fda
flop
gain
hit
j
j’s
labor
littered
medicine
monday
nash
new
news
Language
unset
Current search:
opioid
×
abbvie
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
